Astrana Health Inc. (ASTH)
NASDAQ
Closed
Oct 7, 2026
Day's Range
36.6552 wk Range
18.08Overview - ASTH - Astrana Health Inc.
Key Statistics
Valuation
Enterprise Value
2.24B
P/E (Trailing)
‪44.74‬
P/E (Forward)
‪10.21‬
PEG Ratio
‪0.40‬
Price / Sales (TTM)
‪0.47‬
Price / Book
‪2.20‬
EV / EBITDA
‪12.80‬
Profitability
Gross Margin
‪10.69%‬
Profit Margin
‪1.05%‬
Operating Margin
‪3.52%‬
Return on Assets
‪3.75%‬
Return on Equity
‪6.90%‬
Ownership
Shares Outstanding
49.22M
Float
38.83M
Short % of Shares Outstanding
‪12.57%‬
Held by Insiders
‪22.80%‬
Held by Institutions
‪66.19%‬
Price stats
Beta
‪1.03‬
50-Day Avg
‪37.00‬
200-Day Avg
‪32.82‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
10 analysts
Average price target
‪$ 51.67‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ASTH - Astrana Health Inc.
Peers - ASTH - Astrana Health Inc.
Peer Comparison
Compared with companies in Medical Care Facilities listed on NASDAQ.
Profile Summary - ASTH - Astrana Health Inc.
About
Astrana Health Inc. is a physician-centric healthcare management company that provides integrated medical care services in the United States. Its platform combines care coordination, population health management, and technology-enabled support to help physicians, specialists, hospitals, and health plans deliver…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
